Isolation and characterization of VceC gain-of-function mutants that can function with the AcrAB multiple-drug-resistant efflux pump of Escherichia coli

被引:27
作者
Vediyappan, Govindsamy [1 ]
Borisova, Tatyana [1 ]
Fralick, Joe A. [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Sch Med, Lubbock, TX 79430 USA
关键词
D O I
10.1128/JB.00038-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
VceC is the outer membrane component of the major facilitator (MF) VceAB-VceC multiple-drug-resistant (MDR) efflux pump of Vibrio cholerae. TolC is the outer membrane component of the resistance-nodulation-division AcrAB-TolC efflux pump of Escherichia coli. Although these proteins share little amino acid sequence identity, their crystal structures can be readily superimposed upon one another. In this study, we have asked if TolC and VceC are interchangeable for the functioning of the AcrAB and VceAB pumps. We have found that TolC can replace VceC to form a functional VceAB-TolC MDR pump, but VceC cannot replace TolC to form a functional AcrAB-VceC pump. However, we have been able to isolate gain-of-function (gof) VceC mutants which can functionally interface with AcrAB. These mutations map to four different amino acids located at the periplasmic tip of VceC. Chemical cross-linkage experiments indicate that both wild-type and gof mutant VceC can physically interact with the AcrAB complex, suggesting that these gof mutations are not affecting the recruitment of VceC to the AcrAB complex but rather its ability to functionally interface with the AcrAB pump.
引用
收藏
页码:3757 / 3762
页数:6
相关论文
共 46 条
[1]   Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli [J].
Aires, JR ;
Nikaido, H .
JOURNAL OF BACTERIOLOGY, 2005, 187 (06) :1923-1929
[2]   Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides [J].
Aires, JR ;
Köhler, T ;
Nikaido, H ;
Plésiat, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) :2624-2628
[3]   Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa -: Dual modes of membrane anchoring and occluded cavity end [J].
Akama, H ;
Kanemaki, M ;
Yoshimura, M ;
Tsukihara, T ;
Kashiwagi, T ;
Yoneyama, H ;
Narita, S ;
Nakagawa, A ;
Nakae, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (51) :52816-52819
[4]   Transition to the open state of the ToIC periplasmic tunnel entrance [J].
Andersen, C ;
Koronakis, E ;
Bokma, E ;
Eswaran, J ;
Hymphreys, D ;
Hughes, C ;
Koronakis, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11103-11108
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]   Type I secretion and multidrug efflux: transport through the TolC channel-tunnel [J].
Buchanan, SK .
TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (01) :3-6
[7]   Isolation and characterization of a putative multidrug resistance pump from Vibrio cholerae [J].
Colmer, JA ;
Fralick, JA ;
Hamood, AN .
MOLECULAR MICROBIOLOGY, 1998, 27 (01) :63-72
[8]   ACCESSIBILITY OF F0 SUBUNITS FROM ESCHERICHIA-COLI ATP SYNTHASE - A STUDY WITH SUBUNIT SPECIFIC ANTISERA [J].
DECKERSHEBESTREIT, G ;
ALTENDORF, K .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 161 (01) :225-231
[9]   3D structure of AcrB:: the archetypal multidrug efflux transporter of Escherichia coli likely captures substrates from periplasm [J].
Elkins, CA ;
Nikaido, H .
DRUG RESISTANCE UPDATES, 2003, 6 (01) :9-13
[10]   Three's company: component structures bring a closer view of tripartite drug efflux pumps [J].
Eswaran, J ;
Koronakis, E ;
Higgins, MK ;
Hughes, C ;
Koronakis, V .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2004, 14 (06) :741-747